Cbd

'Ignorance is amok... not even the investors are asking the right questions. It’s total anarchy'

SPECIAL FEATURE: What is the regulatory status of CBD in food and beverage products?

11-Oct-2018 By Elaine Watson

If you ask the FDA or the DEA if CBD (cannabidiol) is permitted in foods, beverages and supplements, the answer is a pretty unequivocal NO. If you ask the scores of companies currently selling it in everything from CBD-infused soda to smoothie kits, the...

Hemp Boom: Thorne’s hemp oil sales exceeds company expectations

27-Sep-2018 By Adi Menayang

Hemp Oil + by legacy supplement company Thorne Research is relatively new, released only in March this year. The product launch proved to be the company’s ‘most successful’ so far, according to one exec.

Canadian cannabis specialist Auxly acquires contract researcher KGK Sciences

24-Aug-2018 By Adi Menayang

Auxly Cannabis Group announced this week that it will acquire contract research organization KGK Sciences.

Cannabis research effort will provide baseline data for CBD products, exec says

27-Jun-2018 By Hank Schultz

A new research partnership between Canadian CRO Nutrasource and a Florida medical clinic will aid the formulators of CBD products by providing baseline data that at the moment is lacking, an executive said.

Market growth continues to fuel CBD ferment

21-Dec-2017 By Hank Schultz

Despite the clouded regulatory picture, development of CBD-based products is continuing in the US.

FDA hardens stance against use of CBD in supplements

03-Nov-2017 By Hank Schultz

The Food and Drug Administration’s attitude that CBD does not belong in dietary supplements seems to have hardened, judging by the wording of four warning letters issued this week.

Colorado CBD brand takes aim at national specialty retail distribution

14-Aug-2017 By Hank Schultz

Colorado-based brand NuLeaf Naturals is expanding its distribution footprint beyond online sales into brick and mortar retail for its line of CBD products.

Bioavailability-boosted CBD hits market

16-Dec-2016 By Hank Schultz

A new form of CBD products that claim greater bioavailability and protection from stomach acid breakdown via a nano droplet technology have hit the market in the US. 

Pressure mounts for regulatory clarity on CBDs

21-Mar-2016 By Hank Schultz

The recent spate of FDA warning letters on the use of CBD as an ingredient in dietary supplements seems to have done little to dampen formulators’ enthusiasm for its use in new products. The situation is unprecedented in the herbal products sphere, observers...

FDA sends warning letters to 8 companies marketing CBD products

10-Feb-2016 By Hank Schultz

The Food and Drug Administration has sent eight warning letters out to companies marketing dietary supplements containing CBD. The warning letters cite illegal drug claims and also hinge upon the existence of CBD as the active ingredient in two drugs...

CBD supplement line launches with test program to donate products to those who can't afford them

03-Dec-2015 By Hank Schultz

Another company offering a CBD dietary supplement has debuted, this time with a way to address the high cost of the products.

Cannavest gets CBD oil products on natural channel retail shelves amid mounting losses

02-Sep-2015 By Hank Schultz

Cannavest, a Las Vegas, NV-based company active in the CBD marketplace, has reported a sharp increase in losses in its second quarter, 2015 earnings statement. But the company also hit the retail market with its PlusCBD Oil product and secured significant...

Canadian company claims its liposomal delivery massively boosts CBD bioavailability

25-Aug-2015 By Hank Schultz

Despite the regulatory haze that clouds the picture of hemp ingredients, innovation continues at an unrestrained pace. In the latest development, early stage company Lexaria says it has developed a liposomal delivery system to boost the bioavailability...

FDA's decision on CBD likely to be overturned after more info comes in, exec says

26-May-2015 By Hank Schultz

An executive with one of the companies promoting cannabidiol for dietary supplements believes that FDA’s recent determination that the compound is not a legal dietary ingredient is premature and will be overturned.

FDA says no to CBD in supplements

18-May-2015 By Hank Schultz

In a recently updated communication on marijuana, the Food and Drug Administration has flatly stated that products based on cannabidiol (CBD), a non-narcotic fraction of Cannabis sativa, cannot be marketed as dietary supplements.  The reason? A pre-existing...

Warning letters to CBD companies hinge on disease claims, sidestep issue of ingredient's legality

04-Mar-2015 By Hank Schultz

Four companies marketing dietary supplement products containing cannabidiol (CBD), a non-narcotic fraction of Cannabis sativa, received warning letters recently from the Food and Drug Administration.  But the letters said nothing about the status of CBD...